"Second Opinion" with Christina Farr, Ash Zenooz MD & Luba Greenwood JD

On the first episode of Second Opinion, Christina Farr, Ash Zenooz, and Luba Greenwood chat with Dr. Robin Berzin, the Founder & CEO of Parsley Health. Robin shares her journey from being a physician to founding Parsley Health, a digital health company that uses root cause medicine to drive powerful outcomes for patients with complex health needs. She also talks about how breakthroughs in data and AI are helping redefine primary care with data-driven insights. They explore crucial healthcare questions like "Whose job is it to prevent chronic disease?" and discuss whether digital health can deliver on prevention, treatment, and longevity. They reflect on the shortcomings of primary care, the impact of the standard American diet on health, the latest studies on cortisol, and the importance of a holistic approach to medicine. Thank you to our sponsor Awell, the leading CareOps platform.—SPONSORS: 👩‍⚕️ Hot flashes, insomnia, brain fog? You don't have to accept these as just another part of aging. Midi Health is the virtual care clinic for women navigating midlife hormonal transition, offering FDA-approved medications, supplements and lifestyle coaching - all covered by insurance. Visit https://www.joinmidi.com/ to book your virtual visit today.🩺 AWELL. Transform your healthcare operations with Awell! Say goodbye to manual work and Excel hell. Awell's CareOps orchestration platform helps design, implement, and improve care flows in days. Trusted by Astrana Health, Commons Clinic, and Better Health, Awell automates processes for faster care model improvements in 2 days or less. Visit awellhealth.com and mention Second Opinion for a free bootcamp.—LINKS:Subscribe to Robin’s Newsletter: https://robinberzinmd.com/ Subscribe to Parsley Health Newsletter: https://www.parsleyhealth.com/blog/category/news/ Parsley Health: https://www.parsleyhealth.com  ARTICLES MENTIONED:Health care's "churn" problem: https://secondopinion.media/p/health-cares-churn-problem How to balance cortisol levels to increase energy and lose weight: https://robinberzinmd.com/how-to-balance-cortisol-levels-to-increase-energy-and-lose-weight/ A Lot of What You’ve Heard About Cortisol Is Wrong: https://www.wsj.com/health/wellness/cortisol-stress-hormone-adrenal-fatigue-02aab49a —FOLLOW:https://www.linkedin.com/in/robin-berzin-md/https://www.linkedin.com/in/christinafarr/https://www.linkedin.com/in/lubagreenwood/https://www.linkedin.com/in/ashzenooz/Subscribe to Second Opinion Newsletter: https://secondopinion.media/ —TIMESTAMPS:(00:00) Intro(02:30) Robin Berzin's Journey: From Physician to CEO of Parsley Health(07:11) Functional Medicine (aka Root Cause Medicine) and Parsley Health(09:31) Challenges in Traditional Healthcare(11:06) The Role of AI and Data in Healthcare(14:34) Whose Job Is It To Prevent Chronic Disease?(21:19) SPONSOR: Awell Health(22:22) Healthcare’s “Churn” Problem, Insurance and Healthcare Costs(27:57) Partnering with Insurance Companies(30:43) How Diet and Lifestyle Impact Health(34:34) The Role of Cortisol in the Body(36:32) WrapThis podcast is part of the Turpentine podcast network. Learn more: turpentine.co

Second Opinion doesn't hold back. Join Christina Farr, Ash Zenooz, Luba Greenwood, as they bring influential entrepreneurs, experts and investors into the ring for candid conversations at the frontlines of healthcare and digital health every week. Episode 1 with Robin Berzin, CEO of Parsley Health, will be available starting on July 31, 2024. Subscribe to Second Opinion wherever you get your podcasts. Learn more at https://www.podpage.com/secondopinion/Til then, meet your hosts:  Christina Farr draws on a decade of experience covering the industry as a reporter at CNBC, Fast Company and Reuters, as well as an investor at OMERS Ventures. During her tenure as a reporter, she broke some big health-tech stories ranging from Amazon’s first moves into the sector to Apple’s secretive acquisitions.  Luba Greenwood, JD is a veteran biotech CEO and investor. She is the managing partner and founder of the Dana-Farber Cancer Institute venture fund and has served as CEO and Chair of multiple companies including Kojin. She has led over $10b in deals and served in leadership roles at large healthcare and tech companies, including Roche and Google. She is a thought leader in the industry and senior lecturer at Harvard. Ash Zenooz, MD — former CEO of Commure and partner at Luxeda Holdings. As former CEO of Commure, she drove over 550% ARR growth and led a merger. Previously, she grew Salesforce's global health and life sciences unit to $2.5b ARR. Ash also served as Chief Medical Officer at the VA, overseeing an $80B portfolio and leading telehealth and precision medicine reforms. This season, we’re tackling meaty topics like biosecurity, the latest in telemedicine, why patient acquisition is so hard, and the pros and cons of VC versus private equity in funding startups in the healthtech space.